1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses

Details for Australian Patent Application No. 2004269889 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Nettekoven, Matthias Heinrich; Jolidon, Synese; Norcross, Roger David; Narquizian, Robert; Pinard, Emmanuel; Stalder, Henri; Alberati-Giani, Daniela

Agent Spruson & Ferguson

Pub. Number AU-B-2004269889

PCT Pub. Number WO2005/023260

Priority 03019686.9 09.09.03 EP

Filing date 30 August 2004

Wipo publication date 17 March 2005

Acceptance publication date 23 July 2009

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/20 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/42 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 237/20 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 295/192 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/14 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 309/14 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023260 Priority application(s): WO2005/023260

23 July 2009 Application Accepted

  Published as AU-B-2004269889

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269892-1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses

2004269882-Composition for the prophylaxis/treatment of HBV infections and HBVmediated diseases